Tag Archives: Lynparza

Drug regulators in China, US and Europe out of the gates in 2020 with a whole month’s worth of action.

Slowly at first, then accelerating recently in its domestic and global footprint in drug research and regulation, China and its National Medical Products Administration (NMPA) has been on a tear…. Read more »

Tesaro says it’s for sale, but who can afford it

The News: Just ahead of the year’s biggest download of cancer data, the maker of a closely watched drug has put itself up for sale, according to The Wall Street… Read more »

Drugs that may shape 2017 and the trends molding new-drug discovery

Here’s a look at the drugs that may shape 2017, compliments of FirstWord Pharma. It’s a list of some of the products I agree are likely to dominate industry news… Read more »

Drugs Targeting DNA Repair Mechanisms Inside Cells Show Promise in Fight Against Cancer

Drugs targeting DNA repair mechanisms inside cells are showing significant promise for a range of tumors and AstraZeneca PLC (London) believes it is well ahead of rivals in the emerging… Read more »